2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Poster Session

[P77] Poster Session 77 Lung Cancer/Thoracic Cancer(SCLC IO)

Kiyoko Fukuda1, Naoko Katsurada1, Kazumi Kaneshiro2, Masataka Matsumoto2, Rei Takamiya3, Yukihisa Hatakeyama3, Ryota Dokuni4, Kanoko Matsumura5, Masahiro Katsurada6, Kyosuke Nakata7, Sho Yoshimura8, Motoko Tachihara1 (1.Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 2.Department of Respiratory Medicine, Kitaharima Medical Center, 3.Department of Respiratory Medicine, Akashi Medical Center, 4.Department of Respiratory Medicine, Hyogo Prefectural Awaji Medical Center, 5.Department of Respiratory Medicine, Takatsuki General Hospital, 6.Department of Internal Medicine, Hyogo Prefectural Tamba Medical Center, 7.Department of Respiratory Medicine, Konan Medical Center, 8.Department of Respiratory Medicine, Steel Memorial Hirohata Hospital)

Tatsuya Yoshida1, Anish Thomas2, Federico Cappuzzo3, Cheng Ying4, Noboru Yamamoto1, Yuanbin Chen5, Alexis B Cortot6, Thierry Berghmans7, NoemÍ Reguart8, Yuji Shibata9, Zhou Jianying10, Camilo Moulin11, Barbara Sarholz12, Jordi Ferrer-Playan11, Anup Kalapur12, Jayaprakasam Bolleddula13, Luis Paz-Ares14 (1.Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan, 2.National Cancer Institute, Bethesda, MD, USA, 3.IRCCS Regina Elena National Cancer Institute, Rome, Italy, 4.Jilin Cancer Hospital, Changchun, China, 5.Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI, USA, 6.Lille University Hospital, Lille, France, 7.Jules Bordet Institute, Brussels, Belgium, 8.Hospital Clinic, Barcelona, Spain, 9.National Cancer Center East Hospital, Chiba, Japan, 10.The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China, 11.Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, 12.Merck Healthcare KGaA, Darmstadt, Germany, 13.EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA, 14.University Hospital 12 de Octubre, Madrid, Spain)

Maiko Asai1,2, Ryo Ko1, Hirotsugu Kenmotsu1, Takumi Fujiwara3, Kosei Doshita1, Hiroaki Kodama1, Naoya Nishioka1, Eriko Miyawaki1, Yuko Iida1, Nobuaki Mamesaya1, Haruki Kobayashi1, Shota Omori1, Kazushige Wakuda1, Akira Ono1, Tateaki Naito1, Haruyasu Murakami1, Toshiaki Takahashi1 (1.Division of Thoracic Oncology, Shizuoka Cancer Center, 2.Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, 3.Department of Pulmonary and Critical Care Medicine, Graduate School of Medicine, Mie University)

Yohei Matsui1, Tadaaki Yamada1, Soichi Hirai1, Osamu Hiranuma2, Shinsuke Shiotsu3, Nobuyo Tamiya4, Takayuki Takeda5, Koichi Takayama1 (1.Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 2.Department of Pulmonary Medicine, Otsu City Hospital, 3.Department of Pulmonary Medicine, Japanese Red Cross Kyoto Daiichi Hospital., 4.Department of Pulmonary Medicine, Rakuwakai Otowa Hospital, 5.Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital)

Masahide Ota1, Akihiro Doi2, Syuichi Oya2, Masato Tasaki1, Hiroyo Ota1, Sigeto Hontsu1, Motoo Yamauchi1, Masanori Yosikawa1, Masayuki Takeda3, Sigeo Muro1 (1.Department of Respiratory Medicine, Nara Medical University, 2.Department of Internal Medicine, Heisei Memorial Hospital, 3.Department of Cancer Genomics and Medical Oncology, Nara Medical University)